Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Tree

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Clinical and Translational Radiation Oncology|October 16, 2023
Prostate cancer image guided radiotherapy: Why the commotion over rectal volume and motion?S E Alexander, U Oelfke, R Westley, et al.
Radiography (London, England : 1995)|April 20, 2021
Evaluation of a urology specialist therapeutic radiographer implemented radiotherapy pathway for prostate cancer patientsS E Alexander, L Booth, L Delacroix, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 2, 2013
Biological dose escalation and hypofractionation: what is there to be gained and how will it best be done?A C Tree, E J Alexander, N J Van As, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 24, 2020
Local Treatment of 'Oligometastases': Wishful Thinking is Not Supported by Available Evidence - Authors' ReplyP H Patel, A-M Shiarli, A C Tree, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 30, 2018
An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary ToxicityD R Henderson, J R Murray, S L Gulliford, et al.
Clinical and Translational Radiation Oncology|June 19, 2025
Ultrahypofractionated radiotherapy for localised prostate cancer: The impact of daily MRI-guided adaptive radiotherapy on delivered doseS E Alexander, R A Mitchell, A Dunlop, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 2015
Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate RadiotherapyD R Henderson, J R Murray, A C Tree, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 22, 2023
Patterns of Failure After Stereotactic Body Radiotherapy to Sacral MetastasesR Ratnakumaran, N van As, V Khoo, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 26, 2022
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided RadiotherapyS E Alexander, H A McNair, U Oelfke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 7, 2014
Prostate stereotactic body radiotherapy—first UK experienceA C Tree, P Ostler, P Hoskin, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Clinical and Translational Radiation Oncology|October 16, 2023
Prostate cancer image guided radiotherapy: Why the commotion over rectal volume and motion?S E Alexander, U Oelfke, R Westley, et al.
Radiography (London, England : 1995)|April 20, 2021
Evaluation of a urology specialist therapeutic radiographer implemented radiotherapy pathway for prostate cancer patientsS E Alexander, L Booth, L Delacroix, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 2, 2013
Biological dose escalation and hypofractionation: what is there to be gained and how will it best be done?A C Tree, E J Alexander, N J Van As, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 24, 2020
Local Treatment of 'Oligometastases': Wishful Thinking is Not Supported by Available Evidence - Authors' ReplyP H Patel, A-M Shiarli, A C Tree, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 30, 2018
An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary ToxicityD R Henderson, J R Murray, S L Gulliford, et al.
Clinical and Translational Radiation Oncology|June 19, 2025
Ultrahypofractionated radiotherapy for localised prostate cancer: The impact of daily MRI-guided adaptive radiotherapy on delivered doseS E Alexander, R A Mitchell, A Dunlop, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 2015
Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate RadiotherapyD R Henderson, J R Murray, A C Tree, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 22, 2023
Patterns of Failure After Stereotactic Body Radiotherapy to Sacral MetastasesR Ratnakumaran, N van As, V Khoo, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 26, 2022
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided RadiotherapyS E Alexander, H A McNair, U Oelfke, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 7, 2014
Prostate stereotactic body radiotherapy—first UK experienceA C Tree, P Ostler, P Hoskin, et al.
Pageof 3